Intellia Therapeutics Prices $180M Stock Offering at Discount
Intellia Therapeutics (NTLA) has priced a public offering of 16.74 million shares at $10.75 each, raising approximately $180 million. The stock is trading down 11% in premarket trading following the announcement. The company's shares closed at $13.20 on Tuesday.
Tickers: $NTLA
Topics: equity financing stock offering stock price movement underwritten offering